First patient dosed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy

PARIS, July 07, 2025 (GLOBE NEWSWIRE) — PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, is pleased to announce that the first patient has been successfully dosed in its Phase I clinical trial (PST-611-CT1) aiming to assess safety and tolerability of its lead program, PST-611, in humans. […]

Theta Capital Announces Senior Hires

Theta Capital Announces Senior Hires GlobeNewswire July 07, 2025 AMSTERDAM, July 07, 2025 (GLOBE NEWSWIRE) — Theta Capital, the largest European investor in blockchain venture capital, has announced two senior hires. Gijs Burgers has been appointed COO, and Eduard van Asten has been appointed Head of Compliance and Risk. Gijs was previously COO at the

First patient dosed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy

First patient dosed in the Phase I clinical trial of PulseSight Therapeutics' PST-611 treatment for dry AMD/Geographic Atrophy GlobeNewswire July 07, 2025 PARIS, July 07, 2025 (GLOBE NEWSWIRE) — PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, is pleased to announce that the first patient has been

Lumissil Microsystems Expands Automotive Lighting Portfolio with Family of High-Side Linear LED Drivers

Lumissil Microsystems Expands Automotive Lighting Portfolio with Family of High-Side Linear LED Drivers Single and Triple Channel Drivers Enhance Thermal Optimization for High-Power Applications GlobeNewswire July 07, 2025 MILPITAS, Calif., July 07, 2025 (GLOBE NEWSWIRE) — Lumissil Microsystems announces the release of the IS32LT315x family, a new line of current-source linear LED drivers designed for

Join Class Action to Recover Losses from Digimarc Corporation (DMRC) – Contact Levi & Korsinsky Before July 7, 2025

NEW YORK, NY / ACCESS Newswire / July 7, 2025 / If you suffered a loss on your Digimarc Corporation (NASDAQ:DMRC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/digimarc-corporation-lawsuit-submission-form-2?prid=155697&wire=1&utm_campaign=31 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Skanska builds multi-sports building in Malmö, Sweden, for about SEK 1 billion

Skanska has signed a contract with the City of Malmö to build a new multi-sports building at the stadium area in Malmö, Sweden. The contract is worth about SEK 1 billion, which will be included in the order bookings for Sweden for the third quarter of 2025. The new building will include a full-size football

The World’s Most Prestigious Street Pole Vault Competition Comes to Asia!

MAKATI CITY, Philippines, July 07, 2025 (GLOBE NEWSWIRE) — Half a century ago, the vibrant city of Manila captured global attention with “Thrilla in Manila,” a historic boxing event. Now, the Philippines is once again opening its doors to a world-class sporting spectacle. On September 20 and 21, 2025, the iconic Ayala Triangle Gardens will

Eleva administers first dose of its Factor H biological treatment in C3-Glomerulopathy to healthy volunteers

First-in-human administration of CPV-104 marks a major step in drug development for the company's lead compound (Factor H) and in bringing a new medication to patients Freiburg im Breisgau, Germany, July 7, 2025 – Eleva, a pioneer in discovering and developing previously inaccessible biologics based on a breakthrough technology platform, announced today the first dosing

Scroll to Top